Overview
- Shares rose 15% for the week to $157.16, marking the stock’s strongest weekly gain since August.
- U.S. District Judge J. Paul Oetken found three ex-employees likely violated confidentiality agreements and ordered them to cease using Palantir data and poaching staff.
- Heightened focus on U.S. operations in Iran lifted defense-tech names, with roughly 60% of Palantir’s revenue tied to government work and its Maven tools reportedly used in the missions.
- Analysts raised or reiterated bullish views, with Rosenblatt lifting its target to $200, Piper Sandler at $230, Citigroup at $260, and UBS upgrading the shares.
- The Pentagon’s blacklisting of Anthropic clouds a prior Palantir–AWS–Anthropic integration, with analysts noting substitutes exist though any switch could slow near-term execution.